Response
We thank Dr Feeman for his interest in our article. 1 His and our data confirm the association of high triglyceride, low HDL cholesterol, and elevated body mass index (BMI) with increased risk for type 2 diabetes, a pattern previously well established. For example, we had previously shown strong and independent associations of elevated BMI and triglyceride and modestly elevated fasting glucose for subsequent diabetes, whereas systolic blood pressure and low HDL cholesterol were not predictive in multivariate analysis. 2 As we noted in our study, one of the major clinical uses for the National Cholesterol Education Program metabolic syndrome criteria could be to identify individuals at elevated risk for type 2 diabetes. It is likely, however, that modifications either in terms of cutoffs or parameters included in the current criteria could help improve diabetes prediction. In this respect, Stern et al 3 recently determined that a simple multivariable model-consisting of readily available clinical measurements and not requiring a 2-hour oral glucose tolerance test-is superior to relying exclusively on the 2-hour glucose value for identifying persons at high risk for future type 2 diabetes. Moreover, the addition of the 2-hour oral glucose tolerance test to the model only minimally enhanced diabetes prediction. 3 What is relatively unique about the West of Scotland Coronary Prevention Study is that it uses a recognized definition in high-risk subjects for heart disease. Clearly, further studies in this important area are required.
